Advances in PET imaging for meningioma patients.
Norbert GalldiksNathalie L AlbertMichael WollringJan-Michael WernerPhilipp LohmannJavier E Villanueva-MeyerGereon R FinkKarl-Josef LangenJoerg-Christian TonnPublished in: Neuro-oncology advances (2023)
In patients with meningioma, diagnosis and treatment planning are predominantly based on anatomical imaging using MRI or CT. Constraints of these imaging modalities include precise meningioma delineation-especially at the skull base, in the case of trans -osseus growth, and in tumors with complex geometry-and the differentiation of post-therapeutic reactive changes from meningioma relapse. Advanced metabolic imaging using PET may help to characterize specific metabolic and cellular features providing additional information beyond the information derived from anatomical imaging alone. Accordingly, the use of PET in meningioma patients is steadily increasing. This review summarizes recent advances in PET imaging helpful for improving the clinical management of patients with meningioma.
Keyphrases
- pet imaging
- high resolution
- end stage renal disease
- optic nerve
- ejection fraction
- positron emission tomography
- newly diagnosed
- computed tomography
- chronic kidney disease
- magnetic resonance imaging
- prognostic factors
- peritoneal dialysis
- healthcare
- contrast enhanced
- health information
- social media
- fluorescence imaging